Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lymphocytotoxic antibodies.

R J DeHoratius1

  • 1Division of Clinical Immunology/Rheumatology, Hahnemann University, Philadelphia, PA 19102.

In Vivo (Athens, Greece)
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Leukocyte Common Antigen (LCA) antibodies modulate immune function, but their exact mechanisms remain unclear. Identifying the specific cell surface antigens targeted by these antibodies is crucial for understanding their role in disease pathogenesis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tuberculous tonsillitis in a patient receiving etanercept treatment.

Annals of the rheumatic diseases·2003
Same author

Calcium apatite crystals in synovial fluid rice bodies.

Annals of the rheumatic diseases·2002
Same author

Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature.

Annals of the rheumatic diseases·2000
Same author

Aseptic meningitis as a side effect of intravenous immune gammaglobulin.

The Journal of rheumatology·1998
Same author

Treatment of acquired factor VIII inhibitor using intravenous immunoglobulin in two patients with systemic lupus erythematosus.

Arthritis and rheumatism·1997
Same author

Acute rheumatic fever.

Cardiovascular clinics·1993
Same journal

Time-Dependent Inflammatory Cytokine Responses in a Human Fetal Membrane Dual-Compartment Model.

In vivo (Athens, Greece)·2026
Same journal

Impact of COVID-19 Vaccine Type on the Efficacy and Safety of Nivolumab in Patients With Metastatic Non-small-cell Lung Cancer: A Multicenter Study.

In vivo (Athens, Greece)·2026
Same journal

Nutritional Support for Treatment Continuity and Survival in Advanced Gastric Cancer: A Propensity Score-matched Study.

In vivo (Athens, Greece)·2026
Same journal

Efficacy of Switching from Prior Nonsteroidal Anti-inflammatory Drugs to Transdermal Diclofenac in Cancer Pain Management.

In vivo (Athens, Greece)·2026
Same journal

Inhibition of Plasminogen Activator Inhibitor-1 (PAI-1) by Tiplaxtinin Attenuates the Aggressive Phenotype of Vulvar Squamous Cell Carcinoma Cells <i>In Vitro</i>.

In vivo (Athens, Greece)·2026
Same journal

Prognostic Value of Liver Function-based Scores in Hepatocellular Carcinoma Patients Undergoing Liver Transplantation.

In vivo (Athens, Greece)·2026
See all related articles

Area of Science:

  • Immunology
  • Molecular Biology
  • Pathology

Background:

  • Leukocyte Common Antigen (LCA) antibodies are observed in various disease states.
  • These antibodies are known to modulate immune function in vitro.
  • The precise mechanisms underlying this immune modulation are not fully understood.

Purpose of the Study:

  • To investigate the role of cell surface antigens in the immune modulation by LCA antibodies.
  • To elucidate the immunopathogenesis of diseases associated with LCA antibodies.

Main Methods:

  • Utilizing recent advances in molecular biological techniques to identify target surface antigens.
  • Analyzing the similarity of identified antigens to antigens on various cell types.

Main Results:

Related Experiment Videos

  • Advances in molecular biology have improved accessibility to target surface antigens.
  • Identification of specific antigens is key to understanding LCA antibody function.

Conclusions:

  • Identifying the specific surface antigen targeted by LCA antibodies is essential for elucidating their exact role.
  • Understanding antigen similarity across cell types may explain the immunopathogenesis of associated diseases.
  • Endothelial cell damage, a common finding, may be linked to these antigen interactions.